Yet despite decades of research, no treatment has been created that arrests Alzheimer’s cognitive deterioration, let alone ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

LATE is a prevalent condition in late life and can contribute to memory loss and cognitive decline, according to report ...

We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...

Alzheimer’s disease is currently the third-leading cause of death among seniors in the U.S., following cardiovascular disease ...

Late-onset Alzheimer's disease is a debilitating, progressive neurodegenerative disease that affects about 7 million ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

The geroscience hypothesis focuses on extending the healthy lifespan by targeting aging mechanisms. Recent advances in ...

Researchers uncover promising evidence that xenon gas, commonly used in anesthesia, may help reduce brain deterioration and ...

Anti-inflammatory drugs like ibuprofen, along with antibiotics, antiviral medications, and vaccines are associated with a ...

The Alzheimer’s Foundation of America is offering scholarships of up to $5,000 to college-bound high school seniors affected ...

Women with amnestic mild cognitive impairment and early Alzheimer’s disease had lower levels of acetyl-L-carnitine and its ...